As they strive to develop new treatments for birth defects, or to prevent them, scientists at the National Institutes of Health have found a big ally in a small fish.
Related posts:
- NIDA supports development of combined anti-heroin and HIV vaccine As they strive to develop new treatments for birth defects, or to prevent them, scientists at the National Institutes of Health have found a big ally in a small fish....
- Rare Disease Day at NIH raises awareness and highlights cutting-edge research The National Institutes of Health will celebrate the Fifth Annual Rare Disease Day February 29 with a day-long celebration co-sponsored by the Office of Rare Diseases Research-National Center for Accelerating Translational Research, and the NIH Clinical Center....
- Medicare, NIH Expands National Network for Transforming Clinical and Translational Research Nine health research centers have received funds to develop ways to reduce the time it takes for clinical research to become treatments for patients. The funds were awarded as part of the Clinical and Translational Science Awards (CTSA) program which is led by the National Center for Research Resources (NCRR), part of the National Institutes […]...
- Video: Suicide Prevention and Research NIMH researcher Dr. Jane Pearson talks about warning signs as well as progress in suicide prevention....
- Reach of national clinical and translational research consortium The National Institutes of Health announced that it will provide $200 million over five years to five health research centers to speed scientific discoveries into treatments for patients. The grants were awarded as part of the Clinical and Translational Science Awards (CTSA) program, which is led by the NIH’s National Center for Research Resources (NCRR)....
- Medicare, NHGRI charts course for the next phase of genomics research Medicare, NHGRI charts course for the next phase of genomics research...
- Common Fund researchers uncover structure of important target for drug design Researchers have uncovered a potent class of small molecules that selectively turn on the S1P1 receptor, a type of receptor in cells that can be targeted in the design of new treatments for diseases such as multiple sclerosis. These findings are reported in the Feb. 17 issue of the journal Science. The research was supported […]...
- Patient-derived stem cells could improve drug research for Parkinson’s Researchers have taken a step toward personalized medicine for Parkinson’s disease, by investigating signs of the disease in patient-derived cells and testing how the cells respond to drug treatments. The study was funded by the National Institutes of Health....
- NIDA Avant-Garde-Medications Development Award winners announced Scientists proposing to develop vaccines against methamphetamine and nicotine have been selected to receive NIDA’s second Avant-Garde Awards for Innovative Medication Development Research. The two scientists, Dr. Thomas Kosten, of Baylor College of Medicine, Houston, and Dr. Peter Burkhard, of the University of Connecticut, Storrs, will each receive $500,000 per year for five years to […]...
- HHS Highlights Innovative New Open Government Initiatives Part of Open Government Commitments in Service of National Priorities Programs Are Result of Accessible Federal Decision Making Process -- HHS Secretary Kathleen Sebelius announced today three innovative HHS ideas that have been developed as a result of a more open and accessible federal decision making process in collaboration between the public, private sector and the federal government....
- Visit National Parks and Recreation Areas If you like to hike, fish, camp, or generally enjoy the great outdoors, visit one of America’s national parks or recreation areas this summer!...
- San Link Inc. Issues an Alert on Uneviscerated Vacuum Pack Dried Krasnoperka (Fish). San Link Inc. Issues an Alert on Uneviscerated Vacuum Pack Dried Krasnoperka (Fish). ...
- Cash Prizes for Business Apps The Apps for Entrepreneurs contest challenges you to develop an app to help small businesses and entrepreneurs navigate the federal government more effectively....
- Funded research provides new clues on how ApoE4 affects Alzheimer’s risk Common variants of the ApoE gene are strongly associated with the risk of developing late-onset Alzheimer’s disease, but the gene’s role in the disease has been unclear. Now, researchers funded by the National Institutes of Health have found that in mice, having the most risky variant of ApoE damages the blood vessels that feed the […]...
- Possible clues found to why HIV vaccine showed modest protection Insights into how the first vaccine ever reported to modestly prevent HIV infection in people might have worked were published online today in the New England Journal of Medicine. Scientists have found that among adults who received the experimental HIV vaccine during the landmark RV144 clinical trial, those who produced relatively high levels of a […]...